Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety of Nivestim® in Patients Treated With Neutropenia-inducing Anticancer Chemotherapy in Routine Practice

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01574235
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:52.556283+00:00
Published At
2015-07-28T00:00:00+00:00
Record Updated At
2015-07-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Solid Tumors", "Malignant Hemopathy", "Chemotherapy-induced Febrile Neutropenia (FN)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-07-28"
protocolSection.identificationModule.nctId
"NCT01574235"
protocolSection.identificationModule.officialTitle
"Safety of Nivestim\u00ae in Patients Treated With Neutropenia-inducing Anticancer Chemotherapy in Routine Practice"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Solid Tumors (protocolSection.conditionsModule.conditions)
  • Malignant Hemopathy (protocolSection.conditionsModule.conditions)
  • Chemotherapy-induced Febrile Neutropenia (FN) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.